Prestige rises after $1.05 billion deal to buy Breathe Right

Shares of consumer healthcare products maker Prestige Consumer Healthcare PBH.N rise 2% to $61.00

Co says it will buy the Breathe Right nasal strip brand, used to ease snoring and blocked noses without drugs, from Foundation Consumer Healthcare

Deal, valued at $1.045 billion, adds a portfolio that made about $200 mln in revenue and about $95 mln in core earnings in 2025, co says

Breathe Right makes up about two-thirds of the acquired sales - PBH

Co says it will pay for the deal with cash and borrowing, and expects debt to rise after the acquisition before falling by fiscal 2028

Says transaction expected to close in the first half of fiscal 2027, subject to approvals

Shares down 21% in 2025